Vimarsana
Biggest News Aggregation in the World

Nasdaq Dnay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Dnay. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Dnay Today - Breaking & Trending Today

Telesis Bio (NASDAQ:DNAY) Trading 0.7% Higher - Vimarsana News

Telesis Bio (NASDAQ:DNAY) Trading 0.7% Higher

Telesis Bio, Inc. (NASDAQ:DNAY – Get Rating)’s share price traded up 0.7% on Thursday . The stock traded as high as $2.92 and last traded at $2.88. 59,993 shares were traded during trading, an increase of 11% from the average session volume of 54,063 shares. The stock had previously closed at $2.86. Telesis Bio Price […]

Source: wkrb13.com
Telesis Bio (NASDAQ:DNAY) Stock Price Down 8.4% - Vimarsana News

Telesis Bio (NASDAQ:DNAY) Stock Price Down 8.4%

Telesis Bio, Inc. (NASDAQ:DNAY – Get Rating) dropped 8.4% during trading on Wednesday . The stock traded as low as $2.64 and last traded at $2.73. Approximately 66,821 shares traded hands during mid-day trading, an increase of 24% from the average daily volume of 54,063 shares. The stock had previously closed at $2.98. Telesis Bio […]

Source: wkrb13.com
Telesis Bio (NASDAQ:DNAY) Trading Down 4.2% - Vimarsana News

Telesis Bio (NASDAQ:DNAY) Trading Down 4.2%

Telesis Bio, Inc. (NASDAQ:DNAY – Get Rating) shares fell 4.2% on Tuesday . The stock traded as low as $2.51 and last traded at $2.76. 232,448 shares were traded during trading, an increase of 330% from the average session volume of 54,063 shares. The stock had previously closed at $2.88. Telesis Bio Trading Up 0.7 […]

Critical Contrast: Codex DNA (DNAY) & Its Competitors - Vimarsana News

Critical Contrast: Codex DNA (DNAY) & Its Competitors

Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Codex DNA to related businesses based on the strength of its risk, valuation, profitability, institutional ownership, dividends, earnings and analyst recommendations. Institutional & Insider Ownership […]

Codex DNA (DNAY) versus The Competition Head-To-Head Survey - Vimarsana News

Codex DNA (DNAY) versus The Competition Head-To-Head Survey

Codex DNA (NASDAQ:DNAY – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Codex DNA to related businesses based on the strength of its earnings, dividends, institutional ownership, profitability, risk, valuation and analyst recommendations. Profitability This table compares Codex DNA […]